Poseida Therapeutics Appoints Mark Gergen as Chief Business Officer and Chief Financial Officer

SAN DIEGO, Feb. 28, 2018 (GLOBE NEWSWIRE) — Poseida Therapeutics Inc. (“Poseida”), a San Diego-based company translating best-in-class gene engineering technologies into lifesaving cell therapies, today announced that Mark J. Gergen, J.D., has joined the company as chief business officer and chief financial officer.